176 related articles for article (PubMed ID: 33486673)
1. Assessment of provider practices regarding venous thromboembolism management and prevention in pediatric acute leukemia patients.
Degliuomini M; Cooley V; Mauer E; Gerber LM; Acharya S; Kucine N
J Thromb Thrombolysis; 2021 Jul; 52(1):209-213. PubMed ID: 33486673
[TBL] [Abstract][Full Text] [Related]
2. Venous thromboembolism in children with acute lymphoblastic leukemia in China: a report from the Chinese Children's Cancer Group-ALL-2015.
Yin M; Wang H; Guan X; Gao J; Yang M; Wang N; Liu T; Tang J; Leung AWK; Zhou F; Wu X; Huang J; Li H; Hu S; Tian X; Jiang H; Cai J; Zhai X; Shen S; Hu Q
Front Med; 2023 Jun; 17(3):518-526. PubMed ID: 36807106
[TBL] [Abstract][Full Text] [Related]
3. Patterns of Venous Thromboembolism Prophylaxis During Treatment of Acute Leukemia: Results of a North American Web-Based Survey.
Lee EJ; Smith BD; Merrey JW; Lee AI; Podoltsev NA; Barbarotta L; Litzow MR; Prebet T; Luger SM; Gore S; Streiff MB; Zeidan AM
Clin Lymphoma Myeloma Leuk; 2015 Dec; 15(12):766-770. PubMed ID: 26363982
[TBL] [Abstract][Full Text] [Related]
4. Venous thromboembolism following L-asparaginase treatment for lymphoid malignancies in Korea.
Lee JH; Lee J; Yhim HY; Oh D; Bang SM
J Thromb Haemost; 2017 Apr; 15(4):655-661. PubMed ID: 28150907
[TBL] [Abstract][Full Text] [Related]
5. L-asparaginase and venous thromboembolism in acute lymphocytic leukemia.
Goyal G; Bhatt VR
Future Oncol; 2015; 11(17):2459-70. PubMed ID: 26274336
[TBL] [Abstract][Full Text] [Related]
6. Venous thromboembolism in pediatric patients with acute lymphoblastic leukemia under chemotherapy treatment. Risk factors and usefulness of thromboprophylaxis. Results of LAL-SEHOP-PETHEMA-2013.
Ruiz-Llobet A; Gassiot S; Sarrate E; Zubicaray J; Dapena JL; Rives S; Sevilla J; Menárguez López Á; Panesso Romero M; Montoya C; Vagace JM; Molina Hurtado JR; García-Morín M; García Abós M; Mendoza Sánchez MC; Lendínez F; Palomo Moraleda P; Tallón M; González B; Urrutia E; Serna JV; Peláez Pleguezuelos I; Martínez Merino M; Ramos Elbal E; Orellana E; Benítez Muñoz H; Berrueco R
J Thromb Haemost; 2022 Jun; 20(6):1390-1399. PubMed ID: 35289066
[TBL] [Abstract][Full Text] [Related]
7. The prevention and management of asparaginase-related venous thromboembolism in adults: Guidance from the SSC on Hemostasis and Malignancy of the ISTH.
Zwicker JI; Wang TF; DeAngelo DJ; Lauw MN; Connors JM; Falanga A; McMasters M; Carrier M
J Thromb Haemost; 2020 Feb; 18(2):278-284. PubMed ID: 31999063
[TBL] [Abstract][Full Text] [Related]
8. A retrospective study of venous thromboembolism in acute leukemia patients treated at the University of Texas MD Anderson Cancer Center.
Vu K; Luong NV; Hubbard J; Zalpour A; Faderl S; Thomas DA; Yang D; Kantarjian H; Kroll MH
Cancer Med; 2015 Jan; 4(1):27-35. PubMed ID: 25487644
[TBL] [Abstract][Full Text] [Related]
9. Incidence and Risk Factors of Venous Thromboembolism in Childhood Acute Lymphoblastic Leukaemia - a Population-Based Analysis of the Austrian Berlin-Frankfurt-Münster (BFM) Study Group.
Gidl A; Füreder A; Benesch M; Dworzak M; Engstler G; Jones N; Kropshofer G; Pötschger U; Poyer F; Tamesberger M; Witt V; Mann G; Attarbaschi A;
Pediatr Hematol Oncol; 2023 Mar; 40(2):181-191. PubMed ID: 35848787
[TBL] [Abstract][Full Text] [Related]
10. Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia.
Rank CU; Lynggaard LS; Als-Nielsen B; Stock W; Toft N; Nielsen OJ; Frandsen TL; Tuckuviene R; Schmiegelow K
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013399. PubMed ID: 33038027
[TBL] [Abstract][Full Text] [Related]
11. Extended anticoagulation for venous thromboembolism: A survey of the American Venous Forum and the European Venous Forum.
Shaydakov ME; Ting W; Sadek M; Aziz F; Diaz JA; Comerota AJ; Lurie F; Blebea J; Eklöf BG; Lugli M; De Maeseneer MGR; Kakkos SK; Nicolaides A; Heim D; Welch HJ;
J Vasc Surg Venous Lymphat Disord; 2022 Sep; 10(5):1012-1020.e3. PubMed ID: 35561974
[TBL] [Abstract][Full Text] [Related]
12. Venous thromboembolism in pediatric patients with sickle cell disease: A north American survey on experience and management approaches of pediatric hematologists.
Betensky M; Kumar R; Hankins JS; Goldenberg NA;
Thromb Res; 2022 Mar; 211():133-139. PubMed ID: 35151008
[TBL] [Abstract][Full Text] [Related]
13. Joint 2022 European Society of Thoracic Surgeons and The American Association for Thoracic Surgery guidelines for the prevention of cancer-associated venous thromboembolism in thoracic surgery.
Shargall Y; Wiercioch W; Brunelli A; Murthy S; Hofstetter W; Lin J; Li H; Linkins LA; Crowther M; Davis R; Rocco G; Morgano GP; Schünemann F; Muti-Schünemann G; Douketis J; Schünemann HJ; Litle VR
Eur J Cardiothorac Surg; 2022 Dec; 63(1):. PubMed ID: 36519935
[TBL] [Abstract][Full Text] [Related]
14. Venous thromboembolism in cancer patients.
Deng A; Galanis T; Graham MG
Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
[TBL] [Abstract][Full Text] [Related]
15. TropicALL study: Thromboprophylaxis in Children treated for Acute Lymphoblastic Leukemia with Low-molecular-weight heparin: a multicenter randomized controlled trial.
Klaassen ILM; Lauw MN; van de Wetering MD; Biemond BJ; Middeldorp S; Abbink FCH; Bierings M; Te Loo DMMW; Pieters R; van der Sluis IM; Tissing WJE; Michel Zwaan C; Heleen van Ommen C
BMC Pediatr; 2017 May; 17(1):122. PubMed ID: 28486976
[TBL] [Abstract][Full Text] [Related]
16. American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism.
Monagle P; Cuello CA; Augustine C; Bonduel M; Brandão LR; Capman T; Chan AKC; Hanson S; Male C; Meerpohl J; Newall F; O'Brien SH; Raffini L; van Ommen H; Wiernikowski J; Williams S; Bhatt M; Riva JJ; Roldan Y; Schwab N; Mustafa RA; Vesely SK
Blood Adv; 2018 Nov; 2(22):3292-3316. PubMed ID: 30482766
[TBL] [Abstract][Full Text] [Related]
17. Fundamental Research in Oncology and Thrombosis 2 (FRONTLINE 2): A Follow-Up Survey.
Kakkar AK; Bauersachs R; Falanga A; Wong J; Kayani G; Kahney A; Hughes R; Levine M
Oncologist; 2020 Jul; 25(7):e1091-e1097. PubMed ID: 32384216
[TBL] [Abstract][Full Text] [Related]
18. Obesity and risk for venous thromboembolism from contemporary therapy for pediatric acute lymphoblastic leukemia.
Prasca S; Carmona R; Ji L; Ko RH; Bhojwani D; Rawlins YA; Mittelman SD; Young G; Orgel E
Thromb Res; 2018 May; 165():44-50. PubMed ID: 29567586
[TBL] [Abstract][Full Text] [Related]
19. Venous Thromboembolism After Peripherally Inserted Central Catheters Placement in Children With Acute Leukemia: A Single-center Retrospective Cohort Study.
Ren Y; Chang L; Zhao B; Zhang X; Wan Y; Zhu X; Zhang H
J Pediatr Hematol Oncol; 2020 Aug; 42(6):e407-e409. PubMed ID: 32427704
[TBL] [Abstract][Full Text] [Related]
20. Anticoagulation prophylaxis reduces venous thromboembolism rate in adult acute lymphoblastic leukaemia treated with asparaginase-based therapy.
Sibai H; Chen R; Liu X; Falcone U; Schimmer A; Schuh A; Law A; McNamara C; Maze D; Yee K; Minden M; Chan SM; Gupta V; Murphy T; Sakurai N; Atenafu EG; Brandwein JM; Seki JT
Br J Haematol; 2020 Dec; 191(5):748-754. PubMed ID: 32395867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
